These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4951970)

  • 1. Oxandrolone therapy in stunting and in ovarian dysgenesis.
    Danowski TS; Weir TF; Girdany B; Lee FA
    Clin Pharmacol Ther; 1967; 8(4):548-53. PubMed ID: 4951970
    [No Abstract]   [Full Text] [Related]  

  • 2. [Growth and skeletal age of girls with gonadal dysgenesis treated with oxandrolone and sex steroids].
    Rybakowa M; Sołtysik-Wilk E; Piatkowska E; Surówka K
    Folia Med Cracov; 1986; 27(3-4):119-27. PubMed ID: 3570085
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of oxandrolone on body height and skeletal maturation in some growth disorders in children].
    Rybakowa M; Król W; Krzyzanowska T
    Pediatr Pol; 1975 Jun; 50(6):735-43. PubMed ID: 1134870
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of constitutional developmental retardation with oxandrolone].
    Novoa Mogollón J; Salto Hernández L; Pérez Pérez C; Alcáñiz Ferrando J; Uriarte Arana A; Moreno Puertas C; Barceló Lucerga B
    Rev Clin Esp; 1981 Sep; 162(6):259-62. PubMed ID: 7330320
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxandrolone treatment of short stature: effect on predicted mature height.
    Bettmann HK; Goldman HS; Abramowicz M; Sobel EH
    J Pediatr; 1971 Dec; 79(6):1018-23. PubMed ID: 4331070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of Turner's syndrome with oxandrolone].
    Vuković D
    Med Pregl; 1983; 36(9-10):409-11. PubMed ID: 6674726
    [No Abstract]   [Full Text] [Related]  

  • 7. [[Considerations on forecasting [corrected] growth after cessation of oxandrolone therapy].
    Rusconi R
    Minerva Pediatr; 1988 Oct; 40(10):585-8. PubMed ID: 3244334
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of oxandrolone on genital development in uncomplicated growth retardation.
    Thompson CG; Cummings CE; Ruvalcaba RH
    Andrologia; 1991; 23(2):163-5. PubMed ID: 1952123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of anabolic steroids: v. effect of prolonged oxandrolone administration on growth in children and adolescents with uncomplicated short stature.
    Moore DC; Tattoni DS; Limbeck GA; Ruvelcaba RH; Lindner DS; Gareis FJ; Al-Agba S; Kelley VC
    Pediatrics; 1976 Sep; 58(3):412-22. PubMed ID: 183178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance of congenital bilateral anorchia in uniovular twins: 17 years of observations on growth and development.
    Ruvalcaba RH; Gogué HP; Kelley VC
    Pediatrics; 1981 Feb; 67(2):276-80. PubMed ID: 7195543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of oxandrolone for growth stimulation in children.
    Jackson ST; Rallison ML; Buntin WH; Johnson SB; Flynn RR
    Am J Dis Child; 1973 Oct; 126(4):481-4. PubMed ID: 4361338
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of constitutional delay of growth and puberty with oxandrolone compared with growth hormone.
    Buyukgebiz A; Hindmarsh PC; Brook CG
    Arch Dis Child; 1990 Apr; 65(4):448-9. PubMed ID: 2346341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of oxandrolone treatment in boys with constitutional delay of growth and puberty.
    Tse WY; Buyukgebiz A; Hindmarsh PC; Stanhope R; Preece MA; Brook CG
    J Pediatr; 1990 Oct; 117(4):588-91. PubMed ID: 2213384
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of constitutional growth delay in prepubertal boys with a prolonged course of low dose oxandrolone.
    Papadimitriou A; Wacharasindhu S; Pearl K; Preece MA; Stanhope R
    Arch Dis Child; 1991 Jul; 66(7):841-3. PubMed ID: 1863096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on anabolic steroids. IV. The effects of oxandrolone on height and skeletal maturation in uncomplicated growth retardation.
    Limbeck GA; Ruvalcaba RH; Mahoney CP; Kelley VC
    Clin Pharmacol Ther; 1971; 12(5):798-805. PubMed ID: 4936144
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxandrolone in low dose for constitutional delay of growth and puberty in boys.
    Stanhope R; Brook CG
    Arch Dis Child; 1985 Apr; 60(4):379-81. PubMed ID: 4004317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Oxandrolone for growth stimulation.
    Rosenblum AL
    Am J Dis Child; 1974 May; 127(5):761. PubMed ID: 4825597
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group.
    Wilson DM; McCauley E; Brown DR; Dudley R
    Pediatrics; 1995 Dec; 96(6):1095-100. PubMed ID: 7491227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.
    Stanhope R; Buchanan CR; Fenn GC; Preece MA
    Arch Dis Child; 1988 May; 63(5):501-5. PubMed ID: 3389864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of short-term growth hormone or low-dose oxandrolone treatment in boys with constitutional growth delay.
    Loche S; Pintor C; Cambiaso P; Lampis A; Carta D; Corda R; Cappa M
    J Endocrinol Invest; 1991 Oct; 14(9):747-50. PubMed ID: 1761810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.